PHYSIOLOGICAL AND PATHOLOGICAL HYPERTROPHY

被引：0
|
作者：
JACOB, R [1 ]
VOGT, M [1 ]
RUPP, H [1 ]
机构：
[1] PHYSIOL INST 2, D-7400 TUBINGEN, FED REP GER
来源：
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 1986年 / 18卷
关键词：
D O I：
10.1016/S0022-2828(86)80135-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [31] Comparative proteomic analysis of mouse models of pathological and physiological cardiac hypertrophy, with selection of biomarkers of pathological hypertrophy by integrative proteogenomics
    Kwon, Hye Kyeong
    Jeong, Hyobin
    Hwang, Daehee
    Park, Zee-Yong
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2018, 1866 (10): : 1043 - 1054
  • [32] Protein Kinase A Is a Master Regulator of Physiological and Pathological Cardiac Hypertrophy
    Bai, Yingyu
    Zhang, Xiaoying
    Li, Ying
    Qi, Fei
    Liu, Chong
    Ai, Xiaojie
    Tang, Mingxin
    Szeto, Christopher
    Gao, Erhe
    Hua, Xiang
    Xie, Mingxing
    Wang, Xuejun
    Tian, Ying
    Chen, Yongjie
    Huang, Guowei
    Zhang, Junping
    Xiao, Weidong
    Zhang, Lili
    Liu, Xueyuan
    Yang, Qing
    Houser, Steven R.
    Chen, Xiongwen
    CIRCULATION RESEARCH, 2024, 134 (04) : 393 - 410
  • [33] Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy
    Abel, E. Dale
    Doenst, Torsten
    CARDIOVASCULAR RESEARCH, 2011, 90 (02) : 234 - 242
  • [34] Modulation of Impact of Obesity in Pathological and Physiological Cardiac Hypertrophy by Orlistat
    Singh, Randhir
    Singh, Manjeet
    Krishan, Pawan
    LATIN AMERICAN JOURNAL OF PHARMACY, 2010, 29 (05): : 754 - 762
  • [35] Unique Cardiac Fibroblast Expression Profiles in Pathological and Physiological Hypertrophy
    Lighthouse, Janet K.
    Velasquez, Lissette S.
    Small, Eric M.
    CIRCULATION RESEARCH, 2014, 115
  • [36] Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy
    Wilkins, BJ
    Dai, YS
    Bueno, OF
    Parsons, SA
    Xu, J
    Plank, DM
    Jones, F
    Kimball, TR
    Molkentin, JD
    CIRCULATION RESEARCH, 2004, 94 (01) : 110 - 118
  • [37] OVARIECTOMY PREVENTS PHYSIOLOGICAL AND POTENTIATES PATHOLOGICAL CARDIAC-HYPERTROPHY
    MALHOTRA, A
    BUTTRICK, PM
    SCHEUER, J
    CIRCULATION, 1987, 76 (04) : 235 - 235
  • [38] Micrornas Have Differential Degree of Expression in Pathological Cardiac Hypertrophy Compared to Physiological Cardiac Hypertrophy
    Martinelli, Nidiane C.
    Cohen, Carolina
    Silvello, Daiane
    Biolo, Andreia
    Andrades, Michael
    dos Santos, Ktia
    Clausell, Nadine
    Rohde, Luis E.
    Matte, Ursula
    CIRCULATION RESEARCH, 2015, 117
  • [39] Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges
    Julia Ritterhoff
    Rong Tian
    Nature Reviews Cardiology, 2023, 20 : 812 - 829
  • [40] IS DYSTROPHIN ABSENCE IMPLICATED IN THE TRANSITION FROM PHYSIOLOGICAL TO PATHOLOGICAL CARDIAC HYPERTROPHY?
    Prado, C.
    Blefari, V.
    Oliveira, D.
    Silva, C. A.
    Fazan, R.
    Salgado, H. C.
    Rossi, M. A.
    HEART, 2013, 99 : A132 - A132
12345